| James Lewis Proffitt, | |
|
2823 Airways Blvd, Jackson, TN 38301-5611 | |
| (731) 293-9946 | |
| Not Available |
| Full Name | James Lewis Proffitt |
|---|---|
| Gender | Male |
| Speciality | Counselor |
| Location | 2823 Airways Blvd, Jackson, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356442636 | NPI | - | NPPES |
| 5441164 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 1618 (Tennessee) | Secondary |
| 101Y00000X | Counselor | PE1618 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Lewis Proffitt, 2823 Airways Blvd, Jackson, TN 38301-5611 Ph: (731) 293-9946 | James Lewis Proffitt, 2823 Airways Blvd, Jackson, TN 38301-5611 Ph: (731) 293-9946 |
News Archive
In a recent bioRxiv* preprint, the large team of researchers evaluated a SARS-CoV-2 Spike receptor-binding domain ferritin nanoparticle protein vaccine (RFN) in a nonhuman primate challenge model. This study addresses the need for a next-generation, efficacious vaccine with an increased pan-SARS breadth of coverage.
Vascular surgeons from Baylor College of Medicine and the Michael E. DeBakey Veterans' Administration Medical Center in Houston, TX, have released a study about the impact of transfusion and postoperative nadir postoperative hemoglobin (nHb) on short- and long-term outcomes after interventions for peripheral arterial disease.
CardiacAssist Inc. announced today that Penrose-St. Francis Health Systems, Colorado Springs, Colo., has adopted the company's TandemHeart® System.
A cancer diagnosis is not necessarily a death sentence. There are now quite a number of possibilities to treat cancer. In addition to radiotherapy and chemotherapy, so-called radionuclide treatment has also become an important component in the fight against the mutated cells. It involves injecting radioactive elements, so-called nuclides, into the patient's circulatory system.
The nano-experts from the Center for Applied Nanotechnology (CAN) GmbH expand their product portfolio by CANdots® Series G - His Detect, which is a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays. It is easy to handle, highly sensitive as well as time saving compared to standard methods available on the market, e.g. ECL.
› Verified 1 days ago